Cargando…
Maternal Supraphysiological Hypercholesterolemia Is Accompanied by Shifts in the Composition and Anti-Atherogenic Functions of Maternal HDL along with Maternal Cardiovascular Risk Markers at Term of Pregnancy
Background: Maternal physiological hypercholesterolemia (MPH) occurs in pregnancy for a proper fetal development. When cholesterol increases over the physiological range, maternal supraphysiological hypercholesterolemia (MSPH) is described, a condition underdiagnosed by a lack of evidence showing it...
Autores principales: | Cantin, Claudette, Morales, Andrea, Serra, Ramón, Illanes, Sebastián E., Leiva, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604113/ https://www.ncbi.nlm.nih.gov/pubmed/37891883 http://dx.doi.org/10.3390/antiox12101804 |
Ejemplares similares
-
Increased Circulating Levels of PCSK9 and Pro-Atherogenic Lipoprotein Profile in Pregnant Women with Maternal Supraphysiological Hypercholesterolemia
por: Cantin, Claudette, et al.
Publicado: (2022) -
Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature
por: Fuenzalida, Bárbara, et al.
Publicado: (2018) -
Cholesterol uptake and efflux are impaired in human trophoblast cells from pregnancies with maternal supraphysiological hypercholesterolemia
por: Fuenzalida, Bárbara, et al.
Publicado: (2020) -
Role for Tetrahydrobiopterin in the Fetoplacental Endothelial Dysfunction in Maternal Supraphysiological Hypercholesterolemia
por: Leiva, Andrea, et al.
Publicado: (2016) -
Gestational Diabetes Mellitus Treatment Schemes Modify Maternal Plasma Cholesterol Levels Dependent to Women´s Weight: Possible Impact on Feto-Placental Vascular Function
por: Contreras-Duarte, Susana, et al.
Publicado: (2020)